Citations 0
Editor's Correspondence
January 26, 1998

Henoch-Schönlein Purpura Induced by Losartan Therapy

Author Affiliations

Copyright 1998 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1998

Arch Intern Med. 1998;158(2):191-192. doi:

Losartan potassium is an orally active, nonpeptide angiotensin II type 1 receptor antagonist that has recently been approved for the treatment of hypertension in many countries.1 Its adverse effects include dizziness, headache, hypotension, renal dysfunction, and hyperkalemia. Uncommon serious adverse events include stroke, worsening heart failure, unstable angina, and myocardial infarction.13

First Page Preview View Large
First page PDF preview
First page PDF preview